Dashboard
Manage Tickers

AFMDAffimed N.V.

Nasdaq affimed.com


$ 6.38 $ -0.30 (-4.49 %)    

Wednesday, 05-Jun-2024 12:50:52 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 4.16 (0.91 %)
DIA $ 398.57 $ 0.17 (0.04 %)
SPY $ 530.36 $ 1.72 (0.32 %)
TLT $ 91.26 $ 0.11 (0.12 %)
GLD $ 225.37 $ 2.44 (1.13 %)
$ 6.68
$ 7.11
$ 6.57 x 100
$ 0.00 x 0
$ 6.26 - $ 7.20
$ 2.24 - $ 8.82
1,836,803
na
101.72M
$ 1.17
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-is-german-biotech-affimed-stock-soaring-on-monday
Why Is German Biotech Affimed Stock Soarin...
06/03/2024 18:13:08

Affimed shares surged after positive updates from the AFM24-102 study in NSCLC. The study reported a 71% disease control rate a...

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

why-affimed-shares-are-soaring
Why Affimed Shares Are Soaring
06/03/2024 16:58:38

Affimed shares are trading higher Monday after the company announced additional follow-up data from the on-going AFM24-102 stud...

affimed-shares-resume-trade
Affimed Shares Resume Trade
06/03/2024 16:35:15

affimed-shares-halted-on-circuit-breaker-to-the-upside-stock-now-up-821
Affimed Shares Halted On Circuit Breaker T...
06/03/2024 16:30:41

hc-wainwright--co-reiterates-buy-on-affimed-maintains-10-price-target
HC Wainwright & Co. Reiterates Buy on Affi...
06/03/2024 11:29:08

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Affimed (NASDAQ:AFMD) with a Buy and maintains $10 price t...

affimed-announced-saturday-in-17-egfr-wild-type-nsclc-patients-who-failed-chemotherapy-and-pd-1pd-l1-afm24-plus-atezolizumab-achieved-4-objective-responses-3-of-4-responses-were-ongoing-for-more-than-7-months-progression-free-survival-was-59-months
Affimed Announced Saturday, In 17 EGFR Wil...
06/02/2024 18:43:54

affimed-says-fda-granted-fast-track-designation-to-combination-of-its-innate-cell-engager-afm24-with-atezolizumab-for-egfr-wild-type-non-small-cell-lung-cancer
Affimed Says FDA Granted Fast Track Design...
05/29/2024 10:32:25

This is for the treatment of patients with advanced and/or metastatic non-small cell lung cancer (NSCLC) not harboring any acti...

affimed-announces-acceptance-of-an-abstract-on-preclinical-data-of-its-innate-cell-engager-afm28-at-the-eha-2024-congress
Affimed Announces Acceptance Of An Abstrac...
05/14/2024 14:12:48

Treatment with AFM28 innate cell engager (ICE®), designed to target CD123-positive cancer cells in patients with acute myeloid ...

affimed-announces-acceptance-of-afm24-clinical-abstract-for-egfr-wildtype-egfrwt-non-small-cell-lung-cancer-nsclc-at-the-2024-annual-meeting-of-the-american-society-of-clinical-oncology
Affimed Announces Acceptance of AFM24 Clin...
04/24/2024 08:08:34

wells-fargo-maintains-overweight-on-affimed-lowers-price-target-to-25
Wells Fargo Maintains Overweight on Affime...
04/01/2024 15:37:33

Wells Fargo analyst Yanan Zhu maintains Affimed (NASDAQ:AFMD) with a Overweight and lowers the price target from $30 to $25.

cantor-fitzgerald-reiterates-overweight-on-affimed
Cantor Fitzgerald Reiterates Overweight on...
04/01/2024 15:15:20

Cantor Fitzgerald analyst Li Watsek reiterates Affimed (NASDAQ:AFMD) with a Overweight.

hc-wainwright--co-maintains-buy-on-affimed-raises-price-target-to-10
HC Wainwright & Co. Maintains Buy on Affim...
04/01/2024 10:36:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Affimed (NASDAQ:AFMD) with a Buy and raises the price targe...

affimed-q4-eps-150-beats-167-estimate-sales-44455k-miss-170m-estimate
Affimed Q4 EPS $(1.50) Beats $(1.67) Estim...
03/28/2024 12:25:02

Affimed (NASDAQ:AFMD) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.67) by 10...

affimed-fy2023-eps-709-down-from-604-yoy-sales-891m-down-from-4135m-yoy-cash-cash-equivalents-and-investments-of-72m-provide-cash-runway-into-2h-2025
Affimed FY2023 EPS €(7.09) Down From €(6.0...
03/28/2024 10:43:34

earnings-scheduled-for-march-28-2024
Earnings Scheduled For March 28, 2024
03/28/2024 09:24:44

Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per ...

a-preview-of-affimeds-earnings
A Preview Of Affimed's Earnings
03/27/2024 15:01:07

affimed-nv-shares-resume-trade
Affimed N.V. Shares Resume Trade
03/11/2024 13:00:28

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
03/11/2024 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
03/09/2024 00:50:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION